Management

Bob van Gemen, CEO

Bob van Gemen has a PhD in molecular biology and spend 10 years at AKZO NOBEL in their diagnostic business unit Organon Teknika. Subsequently he spent 7 years at Primagen Holding BV, a small biotech company based in Amsterdam, the Netherlands, where he fulfilled the position of CEO. During his period at Primagen new molecular diagnostic assays were developed and introduced in the market. An M&S organization was established with a subsidiary in the USA, Primagen Inc., based in Atlanta, Georgia. After a short intermezzo with his own consultancy company he joined Philips on January 1st, 2007 and started the Digital Pathology venture on April 1st, 2007 in the Philips Healthcare Incubator. The Philips Digital Pathology business introduced its first total solution for digitization of pathology in spring of 2011 and generated its first sales in that year. Since November 1st, 2011 he is the CEO of Viroclinics Biosciences BV.

Hans Bunschoten, COO, Deputy CEO
Hans Bunschoten was appointed as Chief Operating Officer of ViroClinics in 2008. Before joining, he worked at various positions within the pharmaceutical industry where he managed drug discovery and the transition of leads into drug candidates for human testing. As a consultant he advised several large pharmaceutical companies in distinct areas of drug development.
Hans was trained in immunology and virology at the National Institute of Public Health and University of Pennsylvania and obtained a PhD from the University of Utrecht. His pharmaceutical career started at Organon Biosciences where he headed multidisciplinary teams in vaccine and drug discovery research. Subsequently, he worked as a Director of Preclinical Development at a Dutch start-up company and as a  management consultant to pharmaceutical companies. Hans has authored many publications and is inventor of numerous patents.

Ab Osterhaus,  CSO
Albert Osterhaus founded ViroClinics BV and is its Chief Scientific Officer. He is professor of virology at the Department of Virology of ErasmusMC, Rotterdam, where he leads a cross-disciplinary team of over 100 scientists, MD's, DVM's, technicians and students..
His interest in virology started while studying for his veterinary degree at the University of Utrecht and he went on to obtain a PhD. He worked at the National Institute of Public Health, becoming Head of Laboratory, prior to moving to Rotterdam. His research activities have grown to span many types of viruses, focussing largely in the respiratory area. He is leading contributor to our understanding of major human pathogens such as hMPV, RSV, influenza and SARS, publishing over 550 papers and an inventor of numerous patents. He has become an internationally respected scientist, serving on editorial boards of several scientific journals and on scientific advisory boards for various international and governmental health organizations, including WHO committees, the National Health Council and he is Chairman of the European Scientific Working Group on Influenza.